Treatment Archives | Pericarditis Alliance

Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis

<img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" class="" width="1080" height="675" srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" />

Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis

by Webmaster | Dec 9, 2022 | News, Press Release, Resources, Treatment

Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis

Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis

by The Pericarditis Alliance | Jun 6, 2022 | Education, Journal, Resources, Treatment

Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis

<img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" class="" width="1080" height="675" srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" />

Cardiol Therapeutics Announces FDA Investigational New Drug Application…

by The Pericarditis Alliance | May 18, 2022 | Press Release, Resources, Treatment

Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis

<img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" class="" width="1080" height="675" srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" />

Kiniksa Announces FDA Approval of Arcalyst

by Dona Winnowski | Aug 14, 2021 | Press Release, Resources, Treatment

THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT

THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT

by Dona Winnowski | Jul 14, 2021 | Education, Journal, Resources, Treatment

Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis

<img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img data-src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" width="1080" height="675" data-srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 1080px; --smush-placeholder-aspect-ratio: 1080/675;" /><noscript><img src="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png" alt="Cardiol Therapeutics Announces Study Results Demonstrating Protective Effects of CardiolRx™ in a Model of Acute Pericarditis" class="" width="1080" height="675" srcset="https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease.png 1080w, https://pericarditisalliance.org/wp-content/uploads/2022/05/media-type-pressrelease-480x480.png 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 1080px, 100vw" />

KINIKSA ANNOUNCES FDA APPROVAL OF ARCALYST ® (RILONACEPT) FOR RECURRENT PERICARDITIS

by Dona Winnowski | Mar 18, 2021 | Press Release, Resources, Treatment

« Older Entries